Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants

Condition: Haemophilus Influenzae Type bInterventions: Biological: GSK Biologicals' Haemophilus influenzae type b vaccine (GSK 208108); Biological: ActHIB™; Biological: Pentacel™; Biological: Pediarix™; Biological: Prevnar 13™; Biological: Rotarix™; Biological: Engerix™-B; Biological: Infanrix™Sponsor: GlaxoSmithKlineCompleted - verified April 2014

http://clinicaltrials.gov/ct2/show/NCT01000974?lup_s=09%2F26%2F2014&lup_d=30

Source: ClinicalTrials.gov - October 22, 2009 Category: Research Source Type: clinical trials